Asthma inhalers account for almost half the pharma giant's carbon footprint, but a new formula promises to slash emissions from the technology by 90 per cent
Asthma inhalers may be a life-saving innovation for millions of people worldwide, but they are also one of the pharmaceutical industries largest sources of greenhouse gas emissions, sparking a race across...
To continue reading this article...
Join BusinessGreen
- Enjoy exclusive news, insights and analysis from Europe’s leading source of information on the green economy and business.
- Make smart, responsible business decisions with an eye on the latest regulatory and tech development
- Tap into our extensive archive of exclusive articles, news, analysis and guide
- Access to our new BusinessGreen intelligence service, providing you with
- > Exclusive in-depth case studies
- > Policy briefings, white papers and reports on market trends that are shaping the direction of the net zero transition
- > Our overnight briefing, expertly curated help you run a competitive and sustainable business
- > Online and interactive meetings with BusinessGreen’s editors to discuss the crucial stories and trends from the past month
Choose the membership package that's right for you and your organisation, via our 3 membership levels.
